China's Best One-Stop Medical Equipment Provider
About

GenDx is a biotechnology company that specializes in high-resolution HLA (human leukocyte antigen) typing and molecular diagnostic testing. Founded in 2005 by Dr. Erik Rozemuller and Dr. Wietse Mulder, the company develops and markets innovative diagnostic tests primarily for transplantation and immunogenetics. GenDx offers advanced molecular diagnostic services and products that enable precise HLA typing, which is essential for matching organ and stem cell donors with recipients. Their product portfolio includes kits and software solutions designed for accurate, high-throughput HLA genotyping, utilizing advanced molecular biology and bioinformatics technologies. GenDx serves clinical laboratories, transplant centers, research institutions, and biotechnology companies, supporting improved patient care in transplantation medicine through better donor-recipient matching and immune response monitoring.

Technologies
Salesforce Outlook MailChimp SPF VueJS LearnDash MemberPress YouTube Google Tag Manager WordPress.org Mobile Friendly Gravity Forms Google Font API Nginx Pardot
Keywords
high resolution hla typing manufacturer of in vitro diagnostics companion diagnostics next generation sequencing hla typing software development chimerism monitoring mrd real time pcr blood group typing custom laboratory services transplant diagnostics ngs cell free dna nanopore sequencing information technology & services
Company Information
  • Employees 71
  • Founded 2005
  • Annual Revenue $19250000
Location

48 Yalelaan, Utrecht, Utrecht, Netherlands, 3584 CM

Related Companies
Companies in the same industry